RVU120, a selective CDK8/CDK19 inhibitor, demonstrates efficacy against hormone-independent breast cancer cells in vitro and in vivo

被引：0
|
作者：
Pakulska, Urszula [1 ]
Obacz, Marta [1 ]
Golas, Aniela [1 ]
Mazan, Milena [1 ]
Masiejczyk, Magdalena [1 ]
Stachowicz, Agata [1 ]
Martyka, Justyna [1 ]
Combik, Michal [1 ]
Keska, Kinga [1 ]
Wiklik, Katarzyna [1 ]
Goller, Kristina [1 ]
Adamczyk, Elzbieta [1 ]
Brzozka, Krzysztof [1 ]
Rzymski, Tomasz [1 ]
机构：
[1] Ryvu Therapeut, Krakow, Poland
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2647
引用
收藏
页数：2
相关论文
共 38 条
  • [1] Selective CDK8/CDK19 inhibitor RVU120 demonstrates efficacy against hormone-independent breast cancer cells in vitro and in vivo
    Rzymski, Tomasz
    Golas, Aniela
    Mazan, Milena
    Pakulska, Urszula
    Masiejczyk, Magdalena
    Stachowicz, Agata
    Martyka, Justyna
    Combik, Michal
    Wiklik, Katarzyna
    Goller, Kristina
    Obacz, Marta
    Adamczyk, Elzbieta
    Brzozka, Krzysztof
    CANCER RESEARCH, 2022, 82 (04)
  • [2] Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors
    Dziadziuszko, R.
    Garralda Cabanas, E.
    Rojas, K.
    Chelstowska, M.
    Blaszkowska, M.
    Dudziak, R.
    Rzymski, T.
    Angelosanto, N.
    Littlewood, P.
    Nogai, H.
    Boni, V.
    Lugowska, I.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S23 - S23
  • [3] Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors
    Jedrzejewski, J.
    Blaszkowska, M.
    Dziadziuszko, R.
    Alonso, G.
    Falkowski, A.
    Rzymski, T.
    Wilkinson, G.
    Kuklik, R.
    Nogai, H.
    Lugowska, I.
    Dawidowska, A.
    Boni, V.
    Rojas, K.
    Pretelli, G.
    Garralda, E.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S15 - S15
  • [4] Synergistic Activity of CDK8/19 Inhibitor RVU120 and MEK Inhibitors in Hormone-Negative Breast Cancer: Implications for Targeted Therapy
    Pakulska, Urszula
    Moszynska, Adrianna
    Martyka, Justyna
    Woznicki, Jerzy
    Adamczyk, Elzbieta
    Obacz, Marta
    Izworska, Kinga Keska
    Wiklik, Katarzyna
    Stachowicz, Agata
    Nogai, Hendrik
    Mazan, Milena
    Rzymski, Tomasz
    CANCER RESEARCH, 2024, 84 (09)
  • [5] Phase I/II trial of RVU120 (SEL120), CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors
    Dziadziuszko, R.
    Lugowska, I.
    Garralda, E.
    Rojas Laimito, K. I.
    Rzymski, T.
    Dudziak, R.
    Littlewood, P.
    Nogai, H.
    Boni, V.
    Fuentes Antras, J.
    Alonso, G.
    Santa Gadea, O. Saavedra
    Kuklik, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S472 - S472
  • [6] Phase I/II trial of RVU120 (SEL120), a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors.
    Dziadziunszko, Rafal
    Garralda, Elena
    Angelosanto, Noemi
    Rzymski, Tomasz
    Dudziak, Renata
    Brzozka, Krzysztof
    Littlewood, Peter
    Nogai, Hendrik
    Glasmacher, Axel G.
    Lugowska, Iwona
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Preclinical and Clinical Evidence for Erythroid-Stimulating Activity of RVU120 CDK8/19 Inhibitor in AML and MDS
    Angelosanto, Noemi
    Maranda, Ewa Lech
    Zaucha, Jan Maciej
    Abboud, Camille N.
    Sroka-Porada, Agnieszka
    Ogrodzinska, Wiktoria
    Kozakowska, Magdalena
    Glowniak-Kwitek, Urszula
    Bukowska-Strakova, Karolina
    Rzymski, Tomasz
    Mazan, Milena
    Pakulska, Urszula
    Goller, Kristina
    Zarzycka, Ewa
    Nogai, Hendrik
    BLOOD, 2023, 142
  • [8] RVU120, a small molecule inhibitor of CDK8/19 kinases, enhances rituximab-driven NK cells-mediated cytotoxicity both in vitro and in vivo
    Bialopiotrowicz-Data, E.
    Dziedzic, K.
    Podkalicka, P.
    Grycuk, K.
    Golas, A.
    Dolata, I.
    Chmielewski, S.
    Pilch, Z.
    Nowis, D.
    Juszczynski, P.
    Rzymski, T.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S56 - S57
  • [9] Targeting CDK8/CDK19 to Disrupt Leukemic Stem Cell-like Population in Acute Myeloid Leukemia: Exploring RVU120 As a Promising Frontline Therapy
    Mazan, Milena
    Pakulska, Urszula
    Moszynska, Adrianna
    Sroka-Porada, Agnieszka
    Szade, Krzysztof Tomasz
    Mikula, Michal
    Kozakowska, Magdalena
    Juszczynski, Przemyslaw
    Wiklik, Katarzyna
    Goller, Kristina
    Obacz, Marta
    Abboud, Camille N.
    Zaucha, Jan Maciej
    Maranda, Ewa Lech
    Angelosanto, Noemi
    Nogai, Hendrik
    Rzymski, Tomasz
    BLOOD, 2023, 142
  • [10] Preclinical and Clinical Signs of Efficacy of RVU120 (SEL120), a Specific CDK8/19 Inhibitor in DNMT3A-Mutated AML
    Rzymski, Tomasz
    Pakulska, Urszula
    Abboud, Camille, Sr.
    Burris, Howard A., Sr.
    Solomon, Scott R.
    Obacz, Marta
    Goller, Kristina
    Combik, Michal
    Zaucha, Jan
    Mazan, Milena
    Mikula, Michal
    Cybulska, Magdalena
    Polak, Anna
    Juszczynski, Przemyslaw
    Jaras, Marcus
    Chapellier, Marion
    Flygare, Johan
    Zawadzka, Magdalena
    Strakova, Karolina Bukowska
    Brzozka, Krzysztof
    Shamsili, Setareh
    Angelosanto, Noemi
    BLOOD, 2021, 138
1234